122 related articles for article (PubMed ID: 38189681)
1. A new chemotherapy strategy for advanced hepatocellular carcinoma with exrahepatic metastasis: predictors of long-term survival.
Sun J; Liu C; He D; Jiang D; Cheng S; Shi J
J Chemother; 2024 Jan; ():1-7. PubMed ID: 38189681
[TBL] [Abstract][Full Text] [Related]
2. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
3. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
4. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases.
Yoo JJ; Lee JH; Lee SH; Lee M; Lee DH; Cho Y; Lee YB; Yu SJ; Kim HC; Kim YJ; Yoon JH; Kim CY; Lee HS
PLoS One; 2014; 9(11):e113926. PubMed ID: 25427152
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
Ueshima K; Ogasawara S; Ikeda M; Yasui Y; Terashima T; Yamashita T; Obi S; Sato S; Aikata H; Ohmura T; Kuroda H; Ohki T; Nagashima K; Ooka Y; Takita M; Kurosaki M; Chayama K; Kaneko S; Izumi N; Kato N; Kudo M; Omata M
Liver Cancer; 2020 Sep; 9(5):583-595. PubMed ID: 33083282
[TBL] [Abstract][Full Text] [Related]
6. Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study.
Sun J; Mao F; Liu C; Zhang F; Jiang D; Guo W; Huo L; Zhou L; Lau WY; Shi J; Cheng S
Signal Transduct Target Ther; 2023 Sep; 8(1):368. PubMed ID: 37752117
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Macrovascular Invasion and Extrahepatic Metastasis in Treatment Naive Hepatocellular Carcinoma: When Is [
Chandra KB; Singhal A
Nucl Med Mol Imaging; 2021 Dec; 55(6):293-301. PubMed ID: 34868378
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with hepatocellular carcinoma and extrahepatic metastasis.
Lee HS
Dig Dis; 2011; 29(3):333-8. PubMed ID: 21829026
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim J; Sinn DH; Choi MS; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW
PLoS One; 2019; 14(3):e0213547. PubMed ID: 30845192
[TBL] [Abstract][Full Text] [Related]
10. Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma.
Morimoto Y; Nouso K; Wada N; Takeuchi Y; Kinugasa H; Miyahara K; Yasunaka T; Kuwaki K; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Yamamoto K
Hepatol Res; 2014 Dec; 44(14):E353-9. PubMed ID: 24552350
[TBL] [Abstract][Full Text] [Related]
11. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy.
Jun L; Zhenlin Y; Renyan G; Yizhou W; Xuying W; Feng X; Yong X; Kui W; Jian L; Dong W; Hongyang W; Lehua S; Mengchao W; Feng S
Oncologist; 2012; 17(7):963-9. PubMed ID: 22653882
[TBL] [Abstract][Full Text] [Related]
12. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Xia F; Wu L; Lau WY; Li G; Huan H; Qian C; Ma K; Bie P
PLoS One; 2014; 9(4):e95889. PubMed ID: 24760012
[TBL] [Abstract][Full Text] [Related]
13. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study.
Nakano M; Tanaka M; Kuromatsu R; Nagamatsu H; Tajiri N; Satani M; Niizeki T; Aino H; Okamura S; Iwamoto H; Shimose S; Shirono T; Koga H; Torimura T;
Cancer Med; 2015 Dec; 4(12):1836-43. PubMed ID: 26471348
[TBL] [Abstract][Full Text] [Related]
15. Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data.
Lee CH; Chang CJ; Lin YJ; Yen CL; Shen CH; Cheng YT; Lin CC; Hsieh SY
JGH Open; 2019 Feb; 3(1):38-45. PubMed ID: 30834339
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
Jearth V; Patil PS; Mehta S; Sundaram S; Seth V; Goel M; Patkar S; Bal M; Rao V
J Clin Exp Hepatol; 2022; 12(3):841-852. PubMed ID: 35677513
[TBL] [Abstract][Full Text] [Related]
17. Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.
Hu Z; Huang P; Zhou Z; Li W; Xu J; Xu K; Wang J; Zhang H
Clin Transl Oncol; 2018 Jun; 20(6):729-739. PubMed ID: 29110217
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract][Full Text] [Related]
19. Segregation of signaling proteins as prognostic predictors for local recurrence and distant metastasis in hepatocellular carcinoma.
Yeh CT; Huang YH; Liang KH; Chang ML; Hsu CW; Chen YC; Chen TC; Yeh TS; Lee WC
Int J Oncol; 2014 Feb; 44(2):491-504. PubMed ID: 24297625
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival.
Luo Y; Huang X; Chen J; Zhang S
Int J Gen Med; 2023; 16():1271-1278. PubMed ID: 37077764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
